Femasys Inc. (FEMY)
NCM · Medical Instruments & Supplies
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation. It also provides FemBloc, a non-surgical female permanent birth control solution. The company offers its products to gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.
Peers in Medical Instruments & Supplies
All in industry →Intuitive Surgical, Inc.
Medline Inc.
Becton, Dickinson and Company
Alcon Inc.
ResMed Inc.
West Pharmaceutical Services, Inc.
The Cooper Companies, Inc.
Align Technology, Inc.
Solventum Corporation
Baxter International Inc.
Recent press releases
April 2026
FEMASYS INC — DEF 14A Filing
# 🧾 What This Document Is This is a **definitive proxy statement (DEF 14A)** for Femasys Inc. It's an official notice and explanation for shareholders ahead of a **Special Meeting on April 29, 2026**. The company is asking shareholders to vote on three critical proposals. Think of it as a detailed
SEC filings
All filings →Insider trades
All insider trades →Femasys Inc. has no reported insider trades in the last 90 days.